TCA
TWST icon

Trifecta Capital Advisors’s Twist Bioscience TWST Stock Holding History

Trifecta Capital Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6K Hold
475
– – ﹤0.01% 201
2025
Q4 		$15.1K Buy
+475
New +$14.8K ﹤0.01% 208

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Trifecta Capital Advisors's TWST Position: Q1 2026 in Review

Trifecta Capital Advisors held its Twist Bioscience (TWST) position steady in Q1 2026 at 475 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #201.

Trifecta Capital Advisors first reported a position in TWST in Q4 2025 and has held it in 2 quarters since. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Trifecta Capital Advisors held 475 shares of Twist Bioscience worth $22.6K as of Q1 2026.
  • Trifecta Capital Advisors left its Twist Bioscience share count unchanged in Q1 2026.
  • Twist Bioscience made up ﹤0.01% of Trifecta Capital Advisors's portfolio in Q1 2026, its #201 holding.
  • Trifecta Capital Advisors first reported a position in Twist Bioscience in Q4 2025 and has held it in 2 quarters since.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Trifecta Capital Advisors's 13F filing for Q1 2026, filed 1 May 2026.